Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 131685, 13 pages
http://dx.doi.org/10.1155/2015/131685
Research Article

Ki-67 Expression in CRC Lymph Node Metastasis Does Not Predict Survival

1Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal
2ICVS/3B’s-PT Government Associate Laboratory, Braga/Guimarães, Campus of Gualtar, 4710-057 Braga, Portugal
3Surgery Department, Hospitalar Center Trás-os-Montes e Alto Douro, Unidade Hospitalar de Chaves, Avenida Dr. Francisco Sá Carneiro, 5400-279 Chaves, Portugal
4Pathology Department, Braga Hospital, Sete Fontes, São Victor, 4710-243 Braga, Portugal
5Coloproctology Unit, Braga Hospital, Sete Fontes, São Victor, 4710-243 Braga, Portugal
6Laboratory of Medical Investigation (LIM) 14, Faculty of Medicine, University of Sao Paulo, 01246-903 São Paulo, SP, Brazil
7Molecular Oncology Research Centre, 14784-400 Barretos, SP, Brazil

Received 4 December 2014; Accepted 2 February 2015

Academic Editor: Konstantinos Arnaoutakis

Copyright © 2015 Sandra F. Martins et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Svagzdys, V. Lesauskaite, D. Pavalkis, I. Nedzelskiene, D. Pranys, and A. Tamelis, “Microvessel density as new prognostic marker after radiotherapy in rectal cancer,” BMC Cancer, vol. 9, article 95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Des Guetz, B. Uzzan, P. Nicolas et al., “Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature,” British Journal of Cancer, vol. 94, no. 12, pp. 1823–1832, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Brenner, M. Hoffmeister, and U. Haug, “Should colorectal cancer screening start at the same age in European countries? Contributions from descriptive epidemiology,” British Journal of Cancer, vol. 99, no. 3, pp. 532–535, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. F. Martins, R. M. Reis, A. M. Rodrigues, F. Baltazar, and A. Filho, “Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies,” World Journal of Clinical Oncology, vol. 2, no. 6, pp. 272–280, 2011. View at Publisher · View at Google Scholar
  5. S. F. Martins, E. A. Garcia, M. A. M. Luz, F. Pardal, M. Rodrigues, and A. L. Filho, “Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer,” Cancer Genomics & Proteomics, vol. 10, no. 2, pp. 55–67, 2013. View at Google Scholar
  6. M. Zavoral, S. Suchanek, F. Zavada et al., “Colorectal cancer screening in Europe,” World Journal of Gastroenterology, vol. 15, no. 47, pp. 5907–5915, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Bosetti, F. Levi, V. Rosato et al., “Recent trends in colorectal cancer mortality in Europe,” International Journal of Cancer, vol. 129, no. 1, pp. 180–191, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. Roreno, Corpo Humano—Roreno—Registo Oncológico Regional do Norte, http://www.roreno.com.pt/p.
  9. M. Malvezzi, P. Bertuccio, F. Levi, C. La Vecchia, and E. Negri, “European cancer mortality predictions for the year 2013,” Annals of Oncology, vol. 24, no. 3, pp. 792–800, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C. G. Pinto, A. T. Paquete, and I. Pissarra, “Colorectal cancer in Portugal,” European Journal of Health Economics, vol. 10, no. 1, pp. S65–S73, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent et al., “Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012,” European Journal of Cancer, vol. 49, no. 6, pp. 1374–1403, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Gurzu, J. Jung, L. Azamfirei, T. Mezei, A. M. Cîmpean, and Z. Szentirmay, “The angiogenesis in colorectal carcinomas with and without lymph node metastases,” Romanian Journal of Morphology and Embryology, vol. 49, no. 2, pp. 149–152, 2008. View at Google Scholar · View at Scopus
  13. S. Cascinu, V. Georgoulias, D. Kerr, T. Maughan, R. Labianca, and M. Ychou, “Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors,” Annals of Oncology, vol. 14, no. 2, pp. 25–29, 2003. View at Google Scholar · View at Scopus
  14. D. D. Alexander, J. Waterbor, T. Hughes, E. Funkhouser, W. Grizzle, and U. Manne, “African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review,” Cancer Biomarkers, vol. 3, no. 6, pp. 301–313, 2007. View at Google Scholar · View at Scopus
  15. H. J. Calvo, G. D. Ortega, R. J. M. Pardo, M. A. J. López, and T. Cubo, “Biologia molecular del processo metastásico del cancer colorectal,” Cirugia Española, vol. 68, pp. 577–587, 2000. View at Google Scholar
  16. S. Y. Zafar, A. P. Abernethy, D. H. Abbott et al., “Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems,” BMC Cancer, vol. 8, article 345, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. L. A. G. Ries, P. A. Wingo, D. S. Miller et al., “The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer,” Cancer, vol. 88, no. 10, pp. 2398–2424, 2000. View at Publisher · View at Google Scholar
  18. R. S. Saad, Y. L. Liu, G. Nathan, J. Celebrezze, D. Medich, and J. F. Silverman, “Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer,” Modern Pathology, vol. 17, no. 2, pp. 197–203, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Barozzi, M. Ravaioli, A. D'Errico et al., “Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel,” Cancer, vol. 94, no. 3, pp. 647–657, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. A. J. Bilchik, M. DiNome, S. Saha et al., “Prospective multicenter trial of staging adequacy in colon cancer: preliminary results,” Archives of Surgery, vol. 141, no. 6, pp. 527–533, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Scholzen and J. Gerdes, “The Ki-67 protein: from the known and the unknown,” Journal of Cellular Physiology, vol. 182, no. 3, pp. 311–322, 2000. View at Publisher · View at Google Scholar
  22. K. Guzinska-Ustymowicz, E. Stepien, and A. Kemona, “MCM-2, Ki-67 and PCNA protein expressions in pT3G2 colorectal cancer indicated lymph node involvement,” Anticancer Research, vol. 28, no. 1, pp. 451–457, 2008. View at Google Scholar · View at Scopus
  23. D. Freitas, M. H. Goulão, E. Camacho et al., “Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study,” Hepato-Gastroenterology, vol. 49, no. 47, pp. 1269–1274, 2002. View at Google Scholar · View at Scopus
  24. H. A. Saleh, H. Jackson, G. Khatib, and M. Banerjee, “Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia,” Pathology & Oncology Research, vol. 5, no. 4, pp. 273–279, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. M. X. Lin, Z.-F. Wen, Z.-Y. Feng, and D. He, “Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues,” Ai Zheng, vol. 27, no. 12, pp. 1321–1326, 2008. View at Google Scholar · View at Scopus
  26. P. Dziegiel, J. Forgacz, E. Suder, P. Surowiak, J. Kornafel, and M. Zabel, “Prognostic significance of metallothionein expression in correlation with Ki-67 expression in adenocarcinomas of large intestine,” Histology and Histopathology, vol. 18, no. 2, pp. 401–407, 2003. View at Google Scholar · View at Scopus
  27. X. Z. Bai, J. R. W. Masters, N. O'Donoghue et al., “Prognostic markers in clinically localised prostate cancer,” International Journal of Oncology, vol. 14, no. 4, pp. 785–791, 1999. View at Google Scholar · View at Scopus
  28. W. X. Gao, J. G. Feng, Y. F. Yang et al., “PCNA in colorectal carcinoma and the prognosis,” Xian Dai Yu Fang Yi Xue, vol. 2, no. 34, pp. 225–229, 2007. View at Google Scholar
  29. M. Micev, M. Micev-Cosić, V. Todorović et al., “Histopathology of residual rectal carcinoma following preoperative radiochemotherapy,” Acta Chirurgica Iugoslavica, vol. 51, no. 2, pp. 99–108, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. F. L. Nussrat, H. H. Ali, H. G. Hussein, and R. J. Al-Ukashi, “Immunohistochemical expression of ki-67 and p53 in colorectal adenomas: a clinicopathological study,” Oman Medical Journal, vol. 26, no. 4, pp. 229–234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Toru and B. Bilezikçi, “Early changes in carcinogenesis of colorectal adenomas,” West Indian Medical Journal, vol. 61, no. 1, pp. 10–16, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Hashimoto, M. Skacel, I. C. Lavery, A. L. Mukherjee, G. Casey, and J. C. Adams, “Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas,” BMC Cancer, vol. 6, article 241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. C. T. F. Oshima, K. Iriya, and N. M. Forones, “Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer,” Neoplasma, vol. 52, no. 5, pp. 420–424, 2005. View at Google Scholar · View at Scopus
  34. C. Evans, I. Morrison, A. G. Heriot et al., “The correlation between colorectal cancer rates of proliferation and apoptosis and systemic levels plus their influence upon survival,” British Journal of Cancer, vol. 94, no. 10, pp. 1412–1419, 2006. View at Publisher · View at Google Scholar
  35. V. Valera, N. Yokoyama, B. Walter, H. Okamoto, T. Suda, and K. Hatakeyama, “Clinical significance of Ki-67 proliferation index in disease progression and prognosis of patients with resected colorectal carcinoma,” British Journal of Surgery, vol. 92, no. 8, pp. 1002–1007, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. H. L. De Menezes, M. J. Jucá, E. G. D. A. Gomes, B. L. B. B. P. Nunes, H. O. Costa, and D. Matos, “Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors,” Arquivos de Gastroenterologia, vol. 47, no. 2, pp. 141–147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Ghiţă, I. D. Vîlcea, M. Dumitrescu et al., “The prognostic value of the immunohistochemical aspects of tumor suppressor genes p53, bcl-2, PTEN and nuclear proliferative antigen Ki-67 in resected colorectal carcinoma,” Romanian Journal of Morphology and Embryology, vol. 53, no. 3, pp. 549–556, 2012. View at Google Scholar · View at Scopus
  38. U. Nabi, A. H. Nagi, and W. Sami, “Ki-67 proliferating index and histological grade, type and stage of colorectal carcinoma,” Journal of Ayub Medical College, Abbottabad, vol. 20, no. 4, pp. 44–48, 2008. View at Google Scholar · View at Scopus
  39. A. Jansson and X.-F. Sun, “Ki-67 expression in relation to clinicopathological variables and prognosis in colorectal adenocarcinomas,” APMIS, vol. 105, no. 9, pp. 730–734, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. C. J. Allegra, S. Paik, L. H. Colangelo et al., “Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study,” Journal of Clinical Oncology, vol. 21, no. 2, pp. 241–250, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Yamauchi, T. Suto, W. Kigure et al., “The progression potential of peritoneal dissemination nodules from gastrointestinal tumors,” International Surgery, vol. 96, no. 4, pp. 352–357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Buxant, V. Anaf, P. Simon, I. Fayt, and J. C. Noël, “Ki-67 immunostaining activity is higher in positive axillary lymph nodes than in the primary breast tumor,” Breast Cancer Research and Treatment, vol. 75, no. 1, pp. 1–3, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Park, R. Kåresen, T. Noren, and T. Sauer, “Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications,” Virchows Archiv, vol. 451, no. 1, pp. 11–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Cabibi, V. Mustacchio, A. Martorana et al., “Lymph node metastases displaying lower Ki-67 immunostaining activity than the primary breast cancer,” Anticancer Research, vol. 26, no. 6B, pp. 4357–4360, 2006. View at Google Scholar · View at Scopus
  45. K. Tawfik, B. F. Kimler, M. K. Davis, F. Fan, and O. Tawfik, “Ki-67 expression in axillary lymph node metastases in breast cancer is prognostically significant,” Human Pathology, vol. 44, no. 1, pp. 39–46, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. F. L. Greene, D. L. Page, I. D. Fleming et al., Eds., AJCC Cancer Staging Manual, Springer, New York, NY, USA, 6th edition, 2002.
  47. C. Pinheiro, A. Longatto-Filho, C. Scapulatempo et al., “Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas,” Virchows Archiv, vol. 452, no. 2, pp. 139–146, 2008. View at Publisher · View at Google Scholar
  48. D. C. Brown and K. C. Gatter, “Monoclonal antibody Ki-67: its use in histopathology,” Histopathology, vol. 17, no. 6, pp. 489–503, 1990. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Gerdes, U. Schwab, H. Lemke, and H. Stein, “Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation,” International Journal of Cancer, vol. 31, no. 1, pp. 13–20, 1983. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Kubota, R. E. Petras, K. A. Easley, T. W. Bauer, R. R. Tubbs, and V. W. Fazio, “Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma: a multivariate analysis,” Cancer, vol. 70, no. 11, pp. 2602–2609, 1992. View at Publisher · View at Google Scholar
  51. M. Hosaka, Y. Takano, M. Iki, and et al, “Prognostic significance of Ki-67, p53, and Bcl-2 expression in prostate cancer patients with lymph node metastases: a retrospective immunohistochemical analysis,” Pathology International, vol. 48, no. 1, pp. 41–46, 1998. View at Publisher · View at Google Scholar · View at Scopus
  52. M. J. Jo, J. Y. Park, J. S. Song et al., “Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer,” World Journal of Gastroenterology, vol. 21, no. 2, pp. 667–674, 2015. View at Publisher · View at Google Scholar
  53. J. Harvey, C. Thomas, B. Wood et al., “Practical issues concerning the implementation of Ki-67 proliferative index measurement in breast cancer reporting,” Pathology, vol. 47, no. 1, pp. 13–20, 2015. View at Publisher · View at Google Scholar
  54. O. Trédan, C. M. Galmarini, K. Patel, and I. F. Tannock, “Drug resistance and the solid tumor microenvironment,” Journal of the National Cancer Institute, vol. 99, no. 19, pp. 1441–1454, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. D. L. Longo, A. S. Fauci, D. L. Kasper, S. L. Hauser, J. L. Jameson, and J. Loscalzo, Eds., Harrison's Principles of Internal Medicine, McGraw-Hill, New York, NY, USA, 18th edition, 2012.
  56. T. E. Le Voyer, E. R. Sigurdson, A. L. Hanlon et al., “Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089,” Journal of Clinical Oncology, vol. 21, no. 15, pp. 2912–2919, 2003. View at Publisher · View at Google Scholar · View at Scopus